ADNP Functions During Early Brain Development and Their Relevance to ASD and ADNP Syndrome
International Journal of Molecular Sciences · 07.07.2026 · 27 (13) · 6085
DOI: 10.3390/ijms27136085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.07.2026. Verfasst von Xiaonan Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, PA 19129, USA. Hauptthemen laut MEDLINE: Brain, Autism Spectrum Disorder, Nerve Tissue Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, United States Department of Defense, NIMH.
Abstract (Originalsprache)
The Activity-Dependent Neuroprotective Protein (ADNP) is an important regulator of early brain development, especially during cortical neurogenesis and neurite formation. De novo point mutations or haploinsufficiency of the ADNP gene result in ADNP syndrome, which is also known as Helsmoortel-Van der Aa syndrome, a complex neurodevelopmental disorder recognized as a leading single-gene cause of syndromic autism spectrum disorder (ASD) and intellectual disability. ADNP works as both a transcription factor and a microtubule (MT) regulator. As a transcription factor, ADNP is a key component of chromatin remodeling complexes such as ChAHP (CHD4 (Chromodomain Helicase DNA-binding Protein 4)-ADNP-HP1 (Heterochromatin Protein 1)) and SWI/SNF (Switch/Sucrose Non-Fermentable), and it tightly regulates the expression of numerous essential developmental genes. ADNP also modulates the Wnt/β-catenin signaling pathway. During neural differentiation, ADNP is redistributed from the nucleus to the cytoplasm, and this redistribution is regulated by binding to 14-3-3 proteins, which are phosphorylated by protein Kinase C (PKC). After relocating to the cytoplasm, ADNP functions as an MT regulator by binding to microtubule end-binding proteins (EB1 and EB3) and Tau to control neurite formation. Previous studies have focused on NAP (also known as Davunetide, a peptide derived from ADNP) in MT regulation and its therapeutic potential for autism spectrum disorder (ASD) and neurodegenerative diseases, such as Alzheimer’s disease. This review highlights the functions of full-length ADNP and NAP in early brain development, particularly in neurogenesis and neurite formation during cortical development. We will also discuss the potential of NAP as a therapeutic medication for neurodevelopmental disorders, especially ASD and ADNP syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, PA 19129, USA.
ORCID-Profile: Xiaonan Liu, Shiena Watanabe, Sierra Coleman, Kazuhito Toyo-Oka
Förderung
- NIMH NIH HHS
- United States Department of Defense
- NIMH
- U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP), Autism Program e
Zitieren
APA
Liu, X., Watanabe, S., Coleman, S., Shih, V., Telfer, W. R., Kansagra, V. D., Drak, L., Pesaladinne, L. R., Kim, D., Sudan, S., Singhal, A., & Toyo-Oka, K. (2026). ADNP Functions During Early Brain Development and Their Relevance to ASD and ADNP Syndrome. International Journal of Molecular Sciences, 27(13), 6085. https://doi.org/10.3390/ijms27136085
Vancouver
Liu X, Watanabe S, Coleman S, Shih V, Telfer WR, Kansagra VD, et al. ADNP Functions During Early Brain Development and Their Relevance to ASD and ADNP Syndrome. International Journal of Molecular Sciences. 2026;27(13):6085. doi:10.3390/ijms27136085
BibTeX
@article{Liu2026,
author = {Liu, Xiaonan and Watanabe, Shiena and Coleman, Sierra and Shih, Vicky and Telfer, William R and Kansagra, Vasu D and Drak, Lilit and Pesaladinne, Laasya Reddy and Kim, Diane and Sudan, Samridhi and Singhal, Anushka and Toyo-Oka, Kazuhito},
title = {ADNP Functions During Early Brain Development and Their Relevance to ASD and ADNP Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {6085},
doi = {10.3390/ijms27136085}
}
EUVIMED